Results 211 to 220 of about 48,035 (283)
Economic Burden of Primary Biliary Cholangitis by Line of Therapy in the United States. [PDF]
Kumar S +7 more
europepmc +1 more source
Innate immunity of bile and cholangiocytes in primary biliary cholangitis. [PDF]
Chen R, Sun Y, Hu Y, Tai W.
europepmc +1 more source
Shared risk factors, clinical features, and tumor characteristics across multiple early‐onset cancer types are shown in this Graphical Abstract. Integrative approaches combining molecular pathology, oncology, and population sciences offer opportunities to clarify underlying mechanisms and help us develop preventive strategies for early‐onset cancers ...
Nobuhiro Nakazawa +17 more
wiley +1 more source
Primary biliary cholangitis. Treatment options in 2025. A narrative review. [PDF]
Angelara M +5 more
europepmc +1 more source
Liver Transplantation in the World: Present Conditions of Liver Transplantation from Cadaver Donors in USA. [PDF]
Marino, Ignazio Roberto +1 more
core
ABSTRACT Background Cholangiocarcinoma (CCA) is the second most common liver malignancy with a dismal prognosis. Liver transplantation of patients with CCA is currently no treatment option backed by guidelines for most of the patients, mainly because of presumably worse outcome.
Sophia Heinrich +16 more
wiley +1 more source
In a nationwide cohort of 10,614 patients with metabolic dysfunction–associated steatotic liver disease (MASLD) hospitalized for cardiovascular disease (CVD), diabetes was present in 4550 patients (43%) and was independently associated with higher in‐hospital mortality and cardiovascular complications.
Soichi Komaki +11 more
wiley +1 more source
Abstract Background The effects of aspirin on hepatic steatosis and fibroinflammation are unclear. The study aimed to examine the association between aspirin use and liver magnetic resonance imaging (MRI)‐derived liver fat and corrected T1 (cT1). Methods We used UK Biobank imaging cohort data.
Qi Feng +4 more
wiley +1 more source

